Janssen Biotech Licenses Alligator Bioscience's Lead Cancer Immunotherapy

News   Aug 13, 2015

 
Janssen Biotech Licenses Alligator Bioscience's Lead Cancer Immunotherapy
 
 
 

RELATED ARTICLES

Cell Technology Used to Treat Osteochondral Knee Defect

News

Autologous cells of stromal vascular fraction were transplanted to a 36-year-old man with the use of fibrin matrix.

READ MORE

Targeting the Engine Room of the Cancer Cell

News

Researchers at Columbia University Irving Medical Center (CUIMC) have developed a highly innovative computational framework that can support personalized cancer treatment by matching individual tumors with the drugs or drug combinations that are most likely to kill them.

READ MORE

Novel Method for Testing Vaccine Safety

News

Scientists from the Institut Pasteur, the CNRS and Sanofi Pasteur have recently developed a novel alternative method to animal testing that can be used to verify the safety of vaccines such as the yellow fever vaccine.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy